Filing Flows › Outset Medical (OM) › Q3 2026 › vs Q3 2025
Outset Medical (OM) Q3 2026 vs Q3 2025 (year over year)
Outset Medical's revenue rose $4.2M (+14%) from $29.4M in Q3 2025 to $33.6M in Q3 2026. The biggest changes: Product +$3.1M (+15%); Service and Other Revenue +$1.0M (+12%).
Outset Medical, Q3 2026: revenue $33.6M (+14% year over year), operating margin -36.5%, net loss $14.7M, operating cash flow −$10.4M. The chart draws each line against Q3 2025, the increases inside each band.
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Consumables Product | $13.2M | $12.2M | $1.0M | +8% |
| Consoles Product | $10.5M | $8.3M | $2.1M | +26% |
| Product | $23.7M | $20.6M | $3.1M | +15% |
| Service and Other Revenue | $9.9M | $8.9M | $1.0M | +12% |
| Revenue | $33.6M | $29.4M | $4.2M | +14% |
| Net loss | $14.7M | $17.8M | −$3.2M | -18% |
| Costs & expenses | $48.3M | $47.3M | $1.0M | +2% |
| Operating costs | $45.9M | $45.2M | $621K | +1% |
| Interest & other, net | $2.3M | $1.6M | $643K | +40% |
| Income tax | $153K | $404K | −$251K | -62% |
| Cost of revenue | $19.9M | $17.8M | $2.1M | +12% |
| Research & development | $5.9M | $5.4M | $522K | +10% |
| Sales & marketing | $11.7M | $13.6M | −$1.8M | -13% |
| General & admin | $8.3M | $8.5M | −$171K | -2% |
| Operating cash sources | $14.7M | $17.8M | −$3.2M | -18% |
| Depreciation & amortization | $666K | $1.0M | −$345K | -34% |
| Share-based compensation | $1.7M | $5.1M | −$3.4M | -67% |
| Working capital & other | $2.0M | $5.4M | −$3.5M | -64% |
| Cash used in operations | $10.4M | $6.3M | $4.1M | +64% |
| Net loss absorbed | $14.7M | $17.8M | −$3.2M | -18% |
Questions
How much did Outset Medical's revenue grow year over year in Q3 2026?
Outset Medical's revenue rose $4.2M (+14%) from $29.4M in Q3 2025 to $33.6M in Q3 2026.
What drove Outset Medical's revenue change in Q3 2026?
Product +$3.1M (+15%); Service and Other Revenue +$1.0M (+12%).